trending Market Intelligence /marketintelligence/en/news-insights/trending/ta-PAzAmuK4-gzcCwBozOg2 content esgSubNav
In This List

Takeda's $62B acquisition of Shire gets approval of Jersey court

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Takeda's $62B acquisition of Shire gets approval of Jersey court

Takeda Pharmaceutical Co. Ltd. said the Royal Court of Jersey approved its $62 billion acquisition of Irish drugmaker Shire PLC.

The Japanese drugmaker, which finally managed to claim Shire in its fifth takeover attempt in May 2018, said the acquisition is expected to close Jan. 8.

The deal has already been approved by the shareholders of both companies, the EU and the Japan Fair Trade Commission.